Jun 11, 2026 03:03PM
May 7, 2026 07:30AM
Apr 2, 2026 08:05AM
Apr 2, 2026 08:05AM
Feb 24, 2026 07:30AM
Feb 17, 2026 08:05AM
Jan 12, 2026 08:07AM Harmony Biosciences forecasts WAKIX revenue to exceed $1 billion in 2026
Jan 12, 2026 08:05AM
Nov 24, 2025 08:06AM
Nov 24, 2025 08:05AM
Nov 19, 2025 08:05AM
Nov 4, 2025 07:30AM
Oct 23, 2025 08:05AM
Oct 23, 2025 08:05AM Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
Aug 5, 2025 07:30AM
Aug 5, 2025 07:30AM
Jun 11, 2025 08:06AM
Jun 11, 2025 08:05AM
Jun 5, 2025 08:06AM
Jun 5, 2025 08:05AM
May 6, 2025 07:30AM Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance ​
Apr 8, 2025 08:05AM
Apr 8, 2025 08:05AM
Mar 24, 2025 08:05AM
Mar 24, 2025 08:05AM
Feb 25, 2025 07:30AM
Feb 19, 2025 08:05AM
Feb 19, 2025 08:05AM Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia
Jan 13, 2025 08:17AM
Jan 13, 2025 08:05AM
Oct 29, 2024 07:30AM
Aug 6, 2024 07:30AM
Aug 6, 2024 07:30AM
Jun 25, 2024 08:09AM
Jun 25, 2024 08:05AM HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
Jun 24, 2024 07:03AM
Jun 24, 2024 07:00AM
Jun 5, 2024 08:06AM
Jun 5, 2024 08:05AM
May 1, 2024 07:15AM
Apr 30, 2024 12:17PM
Apr 30, 2024 07:08AM Harmony Biosciences (HRMY) Acquires Epygenix Therapeutics, Inc.
Apr 30, 2024 07:05AM
Apr 30, 2024 07:00AM
Apr 11, 2024 08:05AM
Apr 3, 2024 08:05AM
Apr 3, 2024 08:05AM
Feb 22, 2024 07:30AM
Feb 21, 2024 08:06AM Harmony Biosciences (HRMY) Announces FDA Grants Priority Review for Application For Wakix (Pitolisant) In Pediatric Narcolepsy
Feb 21, 2024 08:05AM

1,160,146 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All